Information
Address

Gustave Roussy
114, rue Édouard-Vaillant
94805 Villejuif Cedex - France
Switchboard:

Switchboard

+33 (0)1 42 11 42 11

GUSTAVE ROUSSY
1st cancer center in Europe

© 2006-2015 Gustave Roussy – All rights reserved

Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe

back to job offer list
back to clinical trials

Villejuif, 31 July 2026

Route du Rhum 2026 - Jean Le Cam and Christophe Rateau to sail for Gustave Roussy

back to job offer list
back to clinical trials

Villejuif, July 27, 2026

Route du Rhum 2026 
Jean Le Cam and Christophe Rateau to sail for Gustave Roussy

For the Route du Rhum - Destination Guadeloupe 2026, Jean Le Cam and Christophe Rateau will sail under the colors of Gustave Roussy, the leading cancer center in France and Europe. Competing respectively in the Vintage and Class40 categories, the two skippers will carry the Institute's mission to the general public, supporting cancer research and raising awareness of prevention, innovation and patient care.

Biography Birgit Geoerger

back to job offer list
back to clinical trials

Dr Birgit Geoerger

Goûter en Or 2026

back to job offer list
back to clinical trials

À l’occasion de Septembre en Or, mois de mobilisation dédié aux cancers de l’enfant, Gustave Roussy renouvelle son opération Goûter en Or en 2026. Cette grande campagne solidaire invite le public à se mobiliser pour soutenir la recherche contre les cancers pédiatriques et donner de nouvelles chances de guérison aux enfants et adolescents touchés par la maladie.

Owkin and Gustave Roussy partner to bring K Pro into real-world clinical practice

back to job offer list
back to clinical trials

21 july 2026

Owkin and Gustave Roussy partner to bring K Pro into real-world clinical practice

Owkin and Gustave Roussy, Europe's leading cancer center, today announced a partnership to test K Pro directly within the hospital's real-world clinical and research workflows.

Titre publication
07/17/2026

From Gene Discovery to Treatment: How LAG‑3 Opened a New Path in Immunotherapy

“Great Advances in Oncology” – Episode 2/4. Discovered more than three decades ago at Gustave Roussy, the LAG‑3 gene is now at the heart of the development of new anticancer treatments. By targeting it, scientists aim to remove one of the brakes that can limit the immune system’s ability to fight cancer cells. 

Launch of a new Interuniversity Diploma (DIU) in Personalized Cancer Prevention under the auspices of the Universities of Paris-Saclay, Rennes, and Lyon 1

back to job offer list
back to clinical trials

Villejuif, 16 july 2026

Launch of a new Interuniversity Diploma (DIU) in Personalized Cancer Prevention under the auspices of the Universities of Paris-Saclay, Rennes, and Lyon 1

Logos partenaires

Antonela Merlotti, Jean-Baptiste Alberge, Meriem Messaoudene, Carlos Pérez González, Laurianne Scourzic
07/09/2026

Five Gustave Roussy Scientists Appointed as Inserm Research Fellows

Inserm – the French National Institute of Health and Medical Research – is the only French public research organisation entirely dedicated to human health. Each year, its new tenured research fellows are recruited through a highly selective competitive process. For the 2026 edition, five young researchers from Gustave Roussy are among the awardees...
Portrait Pierre Denoix
07/06/2026

The TNM Classification: An Invention Born at Gustave Roussy, Now the Universal Language of Cancer

"Great Advances in Oncology” – Episode 1/4. Developed in the 1940s by Professor Pierre Denoix, the TNM classification has gradually become the tool that enables oncologists worldwide to determine the stage of their patients’ cancer within a unified framework. Still in use today, it reached its 9th edition in 2025.
Pr Éric Vivier
07/03/2026

Prof. Éric Vivier Receives the 2026 William B. Coley Award

The Cancer Research Institute (CRI) has awarded the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology to Prof. Éric Vivier, holder of the Natural Killer (NK) Cell Chair of the Fondation Gustave Roussy. This distinction, one of the most prestigious in cancer immunology, recognizes his body of work, which has profoundly...

Pages